ALX Oncology at ASCO 2027

Jun 4–8, 2027 Chicago, IL ~44k attendees Website

ALX Oncology at ASCO 2027 in Chicago: Booth IH09.

OrganizationASCO 2027 Attendance
ALX Oncology
South San Francisco, CA
alxoncology.com
Biotech companies
Clinical-stage immuno-oncology biotech developing evorpacept, a CD47 blocker, with positive data in HER2-positive gastric cancer.
Booth
Exhibiting at Booth IH09

Explore the full ASCO 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Chicago. Leave your work email and we’ll be in touch.

Privacy

Download the full ASCO 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ALX Oncology

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction